Mineralys Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MLYS)

CUSIP: 603170101

Q4 2024 13F Holders as of 31 Dec 2024

Security type / class
Equity / Common Stock, par value $0.0001 per share
Total 13F shares
46,486,259
Total 13F value
$572,248,542
Holder snapshot 6 signals
Share change
+2,001,929
SEC-reported price per share
$12.31
Number of holders
108
Value change
+$24,847,746
Number of buys
55
Number of sells
30
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
79,235,030

Security key

603170101

Report period

Q4 2024

Institutions

108

Top holders

10

MLYS full security history Ownership snapshot Full 13F holder table Newer quarter: Q1 2025 Previous quarter: Q3 2024 Mineralys Therapeutics, Inc. SEC filings Mineralys Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of MLYS - Mineralys Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
ADAMS STREET PARTNERS LLC
Disclosed value leader
Catalys Pacific, LLC
Comparable rows
15/15
Latest evidence
30 Sep 2024
13F 13D/G Lead comparable stake: 2.3% 13D/G row: ADAMS STREET PARTNERS LLC Showing 1-6 of 15 holder rows.

Quick read

ADAMS STREET PARTNERS LLC leads the comparable SEC ownership view at 2.3%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ADAMS STREET PARTNERS LLC's linked filing trail.
Comparable ownership Top 5
ADAMS STREET PARTNERS LLC 2.3%
Catalys Pacific, LLC 11%
Samsara BioCapital, LLC 6.4%
RA CAPITAL MANAGEMENT, L.P. 6.1%
TCG Crossover Management, LLC 3.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
ADAMS STREET PARTNERS LLC
13F 13D/G
Company
13F 13D/G
2.3%
from 13D/G
$18,560,440
1,532,654 shares
 — 30 Sep 2024
Catalys Pacific, LLC
13F
Company
13F
11%
$104,685,852
8,644,579 shares
 — 30 Sep 2024
Samsara BioCapital, LLC
13F
Company
13F
6.4%
$61,457,233
5,074,916 shares
 — 30 Sep 2024
RA CAPITAL MANAGEMENT, L.P.
13F
Company
13F
6.1%
$58,745,416
4,850,984 shares
 — 30 Sep 2024
TCG Crossover Management, LLC
13F
Company
13F
3.1%
$29,914,909
2,470,265 shares
 — 30 Sep 2024
BlackRock, Inc.
13F
Company
13F
2.7%
$25,965,874
2,144,168 shares
 — 30 Sep 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
108
Shares
46,486,259
Rows available
108
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders
105
Q4 2024 holders
108
Holder diff
3
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 value Q4 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .